Nico Gagelmann

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Nico Gagelmann
Jun 18, 2025, 15:13 | Insight
Nico Gagelmann: Closing the Gap - PTCy Boosts Survival After Mismatched Stem Cell Transplants
Nico Gagelmann, Young National Society Ambassador at European Hematology Association (EHA) and Chair of the…
Jun 17, 2025, 07:45 | Insight
Alexandra Martínez-Roca: Privileged to Share the Stage With Leading Voices In Hematology at EHA 2025
Alexandra Martínez-Roca, Hematologist at the Hematology Department at the Hospital Clínic Barcelona, shared a post…
Jun 16, 2025, 18:35 | Societies
25 Posts Not to Miss from EHA 2025
The European Hematology Association (EHA) Congress 2025 is officially underway in Milan. From June 12…
Jun 15, 2025, 08:40 | Blog
7 Posts Not to Miss From the EHA 2025 – Nico Gagelmann
The European Hematology Association (EHA) 2025 events bring together global experts to explore the latest…
Jun 14, 2025, 18:04 | Science
Nico Gagelmann Shares Article on How Remission Conversion Drives Outcomes After CAR T-cell Therapy for Multiple Myeloma
Nico Gagelmann, Young National Society Ambassador at European Hematology Association (EHA) and Chair of the…
Jun 13, 2025, 09:06 | Science
Myeloma Paper of the Day, June 13th, suggested by Robert Orlowski
Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas…
Jun 13, 2025, 08:36 | Insight
Nico Gagelmann: Highlights from EHA 2025 - Breakthroughs in ET, Myelofibrosis, MM, MDS, and BPDCN
Nico Gagelmann, Chair of the CAR-T for plasma cell disorder committee at the EBMT, shared…
Apr 1, 2025, 06:34 | Blog
Trainee Day provided a space for trainees to connect and grow within the EBMT community
The EBMT posted on X: "Yesterday's Trainee Day provided a dedicated space for trainees to…
Mar 24, 2025, 12:31 | Insight
Nico Gagelmann: Lower chronic graft-versus-host disease with ruxolitinib plus photopheresis post-transplant
Nico Gagelmann, Young National Society Ambassador at European Hematology Association (EHA), shared on LinkedIn about…
Mar 22, 2025, 12:47 | Blog
Naveen Pemmaraju: Role of allo-HCT in "nonclassical" MPNs and MDS/MPNs
Naveen Pemmaraju, Professor and Director of the BPDCN Program at the Department of Leukemia at…
Mar 14, 2025, 16:20 | Science
Nico Gagelmann: Allogeneic stem cell transplant for Myelofibrosis and Myelodysplastic Syndromes
Nico Gagelmann, Chair of the CAR-T for plasma cell disorder committee at the EBMT, shared…
Feb 25, 2025, 10:45 | Blog
Nico Gagelmann: Join us for the next COSTEM in Berlin
Nico Gagelmann, Chair of the CAR-T for plasma cell disorder committee at The EBMT, shared…
Feb 12, 2025, 17:17 | Blog
Nico Gagelmann: PTCy unchained in matched siblings
Nico Gagelmann, Chair of the CAR-T for plasma cell disorder committee at The EBMT, shared…
Feb 12, 2025, 08:25 | Blog
Nico Gagelmann: It's More Than Complex - Further Insights Into TP53 in MPN
Nico Gagelmann, Chair of the CAR-T for plasma cell disorder committee at The EBMT, shared…
Feb 10, 2025, 09:57 | Blog
Nico Gagelmann: Make CART Affordable Again
Nico Gagelmann, Chair of the CAR-T for plasma cell disorder committee at The EBMT, shared…
Feb 6, 2025, 06:38 | Insight
Learning hematology in 2025 with Nico Gagelmann: Part 3
Nico Gagelman is a physician and scientist who co-founded and co-chairs the European Society for Blood…
Jan 25, 2025, 15:21 | Insight
Learning hematology in 2025 with Nico Gagelmann: Part 2
Nico Gagelman is a physician and scientist who co-founded and co-chairs the European Society for…
Jan 19, 2025, 22:11 | Insight
Nico Gagelmann: Ide-cel versus cilta-cel for relapsed or refractory multiple myeloma
Nico Gagelmann, Chair of the CAR-T for plasma cell disorder committee at The EBMT, shared…
Jan 18, 2025, 11:00 | Science
Myeloma Paper of the Day, January 18th, suggested by Robert Orlowski
Robert Orlowski shared a post on X: “Myeloma Paper of the Day: International multi-center observational study…
Jan 14, 2025, 15:01 | Career
OncoInfluencers to Follow on Social Media: Nico Gagelmann
We’re excited to feature Nico Gagelmann, a distinguished physician and scientist, as our next oncoinfluencer.…
Jan 14, 2025, 12:50 | Science
Clearance of Driver Mutations after Transplantation for Myelofibrosis by Nico Gagelmann et al.
Eddie Cliff, Haematology Registrar at Peter MacCallum Cancer Centre, shared a post on X about a…
Jan 14, 2025, 08:20 | Science
Nico Gagelmann: GSI: myeloma - cold case closed?
Nico Gagelmann, Co-founder of the European Society for Blood and Marrow Transplantation (EBMT) Trainee Committee,…
Jan 13, 2025, 22:32 | Insight
Nico Gagelmann: Let's learn hematology in 2025
Nico Gagelmann, Co-founder and Co-chair of the European Society for Blood and Marrow Transplantation (EBMT)…
Jan 13, 2025, 09:24 | Science
Nico Gagelmann: Clearance of driver mutations after transplantation for myelofibrosis
Nico Gagelmann, Co-founder and Co-chair of the European Society for Blood and Marrow Transplantation (EBMT)…
Jan 11, 2025, 15:00 | Insight
Nico Gagelmann: The power of transplantation to reverse-engineer ‘chronic’ disease
Nico Gagelmann, Co-founder and Co-chair the European Society for Blood and Marrow Transplantation (EBMT) Trainee…
Dec 31, 2024, 09:57 | Insight
Nico Gagelmann: New year's resolutions of academics
Nico Gagelmann, Co-founder and Co-chair the European Society for Blood and Marrow Transplantation (EBMT) Trainee…
Dec 30, 2024, 13:52 | Science
Nico Gagelmann: Selected clinical studies 2024 in hematology
Nico Gagelmann, Co-founder and Co-chair the European Society for Blood and Marrow Transplantation (EBMT) Trainee…
Dec 30, 2024, 13:23 | Insight
Satya Prakash Yadav: 2024 blockbuster Menin inhibitor for infant ALL
Satya Prakash Yadav, Director of Pediatric Hematology Oncology and Bone Marrow Transplant at Medanta, shared…
Dec 13, 2024, 15:39 | Societies
Best of 66th ASH Annual Meeting and Exposition
The 66th ASH Annual Meeting and Exposition was held from December 7-10, 2024, in San…
Dec 12, 2024, 13:36 | Insight
Nico Gagelmann: Tandem transplant for myeloma patients with sub-optimal responses to induction therapy
Nico Gagelmann, Co-founder and Co-chair the European Society for Blood and Marrow Transplantation (EBMT) Trainee…
Dec 12, 2024, 13:11 | Societies
Highlights from Day 4 of 66th ASH Annual Meeting
The 66th ASH Annual Meeting and Exposition was held from December 7-10, 2024, in San…
Dec 11, 2024, 17:45 | Insight
Nico Gagelmann: No hematology without friendship
Nico Gagelmann, Co-chair of EBMT’s Trainee Committee, shared on X: “No hematology without friendship. Thanks…
Dec 11, 2024, 14:33 | Blog
The role of ABO matching in stem cell transplant
Nico Gagelmann, Co-chair of EBMT’s Trainee Committee, shared a post on X: "Nailed the talk…
Dec 8, 2024, 06:51 | Insight
Nico Gagelmann: Suggesting Bispecific Antibodies as Standard of Care for Relapse After CAR-T in Multiple Myeloma
Nico Gagelmann, Co-chair of EBMT’s Trainee Committee, shared a recent article on X: "Finally out…
Dec 8, 2024, 06:21 | Insight
Understanding and treating myelofibrosis
Nico Gagelmann shared a post on X: "Understanding and treating myelofibrosis A short thread on…
Dec 3, 2024, 18:12 | Insight
Nico Gagelmann: Happy to present first European comparison of cilta-cel vs ide-cel for myeloma at ASH24
Nico Gagelmann, Co-chair of EBMT’s Trainee Committee, shared on X: “Happy to present first European…
Nov 21, 2024, 19:17 | Blog
Nico Gagelmann: Role of molecular alterations in transplant decision for primary myelofibrosis
Nico Gagelmann , Co-chair of EBMT’s Trainee Committee, shared on X: "Finally out. Role of molecular…
Nov 15, 2024, 17:47 | Blog
Nico Gagelmann: Current status and Future directions for CAR-T Therapy
Nico Gagelmann, Co-chair of EBMT’s Trainee Committee, shared a post on X: "Chimeric antigen receptor T…
Nov 12, 2024, 03:40 | Blog
Nico Gagelmann: 10 Rules for life as a senior - a trainee's perspective
Nico Gagelmann, Co-chair of EBMT's Trainee Committee, shared a post on X: "10 Rules for…
Nov 2, 2024, 02:19 | Insight
Nico Gagelmann: Remarkable and forgotten women in the history of medicine and science
Nico Gagelmann, Physician and scientist and also serves as the chair of the EBMT subcommittee,…
Nov 1, 2024, 15:46 | Blog
Nico Gagelmann: Recognizing Methotrexate Toxicity - A Case of Severe Anemia in a patient with Rheumatoid Arthritis
Nico Gagelmann, Young National Society Ambassador at European Hematology Association (EHA), shared a post on…
Oct 31, 2024, 06:01 | Insight
Nico Gagelmann: Bs Abs as bridging to BCMA CAR-T cell therapy for R/R multiple myeloma
Nico Gagelmann, Co- Chair of the The EBMT Trainee Committee, shared on X: “Finally out!…
Oct 24, 2024, 15:45 | Blog
Myeloma Paper of the Day, October 24th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Paper of the Day: Bispecific antibodies as bridging to BCMA…
Oct 21, 2024, 15:36 | Blog
Nico Gagelmann: Call for Abstracts for the EBMT and EHA CAR-T Cell Meeting
Nico Gagelmann posted on X: "Call for Abstracts/Cases: The EBMT and The EHA CAR-T Cell…
Oct 19, 2024, 16:40 | Blog
Nico Gagelmann: Honored to Receive ASH Abstract Achievement Award
Nico Gagelmann, Co-founder and co-chair the European Society for Blood and Marrow Transplantation (EBMT) Trainee…
Oct 17, 2024, 01:11 | Societies
Highlights from DGHO24
The 2024 Annual Meeting of the German, Austrian, and Swiss Societies for Hematology and Medical…
Oct 15, 2024, 14:04 | Blog
Nico Gagelmann: Young hematologists and oncologists at DGHO24
Nico Gagelmann, Young National Society Ambassador at European Hematology Association (EHA) shared on X: "Young hematology…
Aug 13, 2024, 09:14 | History
A brief history of blood and its transfusion by Nico Gagelmann
Nico Gagelmann, Chair of CAR-T for plasma cell disorder committee and Chair Trainee Committee at The…
Aug 8, 2024, 10:11 | Blog
Nico Gagelmann: Fast and furious: CAR-T cells in multiple myeloma
Nico Gagelmann, Chair of CAR-T for plasma cell disorder committee and Chair Trainee Committee at The…
Aug 5, 2024, 14:06 | Insight
Nico Gagelmann: Allogeneic hematopoietic cell transplantation for myelofibrosis aged 70 years or older
Nico Gagelmann, Chair of CAR-T for plasma cell disorder committee and Chair Trainee Committee at The…
Jul 29, 2024, 23:27 | Blog
Nico Gagelmann: Being an academic in 2024
Nico Gagelmann, Chair of CAR-T for plasma cell disorder committee and Chair Trainee Committee at The…
Jun 10, 2024, 05:09 | Insight
Saurabh Zanwar: Impact of Extramedullary Multiple Myeloma on Outcomes with Ide-cel
Saurabh Zanwar, Assistant Professor at Mayo Clinic, shared on X: “Out now in Journal of…
May 22, 2024, 12:03 | Insight
Nico Gagelmann: Spotter in hematology. A short thread with some snapshots and diagnosis
Nico Gagelmann, Chair of CAR-T for Plasma Cell Disorder Committee and Chair Trainee Committee at…
May 12, 2024, 04:15 | Blog
Nico Gagelmann: Big achievement in JCO on timing of transplantation for patients with MDS
Nico Gagelmann, Chair of CAR-T for Plasma Cell Disorder Committee and Chair Trainee Committee at The…
Apr 20, 2024, 01:20 | Blog
Nico Gagelmann: Honored to receive one of the best young abstracts awards of EBMT24
Nico Gagelmann, Co-chair at the EBMT Trainee Committee, shared on X/Twitter: "Honored to receive one…
Apr 17, 2024, 18:26 | Blog
Nico Gagelmann: There is nothing like friendship through professional admiration
Nico Gagelmann, Chair of CAR-T for plasma cell disorder committee and Chair Trainee Committee at…
Apr 13, 2024, 11:41 | Insight
Nico Gagelmann: Methodological challenges in the development of endpoints for myelofibrosis clinical trials
Nico Gagelmann, Chair of CAR-T for plasma cell disorder committee and Chair Trainee Committee at…
Jan 9, 2024, 18:48 | Blog
Nico Gagelmann: Gastrointestinal (GI) manifestations in hematology
Nico Gagelmann, Co-Chair for the European Society for Blood and Marrow Transplantation (EBMT) Trainee Committee, shared…
Jan 4, 2024, 17:10 | Opinion
Nico Gagelmann: Still in 2023, academic publishing and scientific conferences are the following
Nico Gagelmann, Co-Chair of the EBMT Trainee Committee, shared on X/Twitter: "Still in 2023, academic…
Jul 3, 2023, 18:40 | Blog
We propose molecular monitoring + donor lymphocyte infusion as standard of care for relapsed myelofibrosis after BMT
In a post by Nico Gagelmann on Twitter, it says, "We propose molecular monitoring +…
All: 60 Posts: 1 - 100
Special Coverage